🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Endothelin-1 (ET-1) has been linked to a number of conditions including pul...
Status
Completed
Location
Clinical Research Centre, Western General Hospital
Start Date
2009-01
Trial ID
NCT01100736
Treatments Being Tested
Sitaxsentan has a low drug-drug interaction potential and it did not have a...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2010-11
Trial ID
NCT01244620
Treatments Being Tested
Introduction. Despite adequate steroid therapy, a subpopulation of approxim...
Status
Terminated
Location
Clinical Investigation center 07, Hopital Bichat
Start Date
2009-11
Trial ID
NCT01050491
Treatments Being Tested
This is a multi-center, randomized study of sitaxsentan administered intrav...
Status
Completed
Location
University of Pennsylvania,
Start Date
2006-08-10
Trial ID
NCT00838383
Treatments Being Tested
The objectives of this study are to develop research methods and correspond...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-01
Trial ID
NCT01445873
Treatments Being Tested
The Thelin Patient Safety Registry is a post-marketing program in the Europ...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2010-04
Trial ID
NCT00995566
Treatments Being Tested
Our goal is to determine clinically in Pulmonary Arterial Hypertension pati...
Status
Withdrawn
Location
Allegheny General Hospital
Start Date
2005-07
Trial ID
NCT00593905
Treatments Being Tested
Patients with chronic kidney disease (CKD) have higher blood pressures than...
Status
Completed
Location
Clinical Research Centre, Western General Hospital
Start Date
2007-07-14
Trial ID
NCT00817037
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of Thelin™...
Status
Completed
Location
Encysive Pharmaceuticals
Start Date
2003-05
Trial ID
NCT00080457
Treatments Being Tested
The purpose of this study is to investigate safety, tolerability and pharma...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-09
Trial ID
NCT00981968
Treatments Being Tested